VITAMIN K1 Drug Patent Profile
✉ Email this page to a colleague
When do Vitamin K1 patents expire, and when can generic versions of Vitamin K1 launch?
Vitamin K1 is a drug marketed by Hospira and is included in three NDAs.
The generic ingredient in VITAMIN K1 is phytonadione. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vitamin K1
A generic version of VITAMIN K1 was approved as phytonadione by AMNEAL PHARMS CO on May 11th, 2018.
Summary for VITAMIN K1
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Patent Applications: | 3,627 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | VITAMIN K1 at DailyMed |
Pharmacology for VITAMIN K1
| Drug Class | Vitamin K Warfarin Reversal Agent |
| Physiological Effect | Increased Prothrombin Activity Reversed Anticoagulation Activity |
US Patents and Regulatory Information for VITAMIN K1
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | VITAMIN K1 | phytonadione | INJECTABLE;INJECTION | 087954-001 | Jul 25, 1983 | BP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hospira | VITAMIN K1 | phytonadione | INJECTABLE;INJECTION | 087955-001 | Jul 25, 1983 | AB1 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hospira | VITAMIN K1 | phytonadione | INJECTABLE;INJECTION | 087956-001 | Jul 25, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
